Bionovo reports positive Menerba clinical program meeting with FDA

[News]

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of innovative treatments for women's health and cancer, today announced that it had received the minutes from the U.S. Food and Drug Administration's (FDA) Clinical Guidance meeting that took place on November 8, 2010. In that meeting, the FDA agreed with the Company's proposed overall clinical development plan.

More... (http://www.news-medical.net/news/20101213/Bionovo-reports-positive-Menerba-clinical-program-meeting-with-FDA.aspx)